However, a recent publication, based on tumor tissue derived from hepatocellular carcinoma patients and from an animal model, reports that activated Akt signaling, a typical feature of temsirolimus resistance [2], may correlate with ITGA7 expression and tumor metastasis [27]. Here, AKT1 is linked to hepatocellular carcinoma.